Detalles de la búsqueda
1.
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.
Nat Immunol
; 23(2): 210-216, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35027728
2.
Associations between antiretroviral regimen and changes in blood pressure: results from the D2EFT study.
Clin Infect Dis
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721980
3.
Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020.
Liver Int
; 44(4): 1024-1031, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291946
4.
Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review.
Clin Infect Dis
; 77(Suppl 3): S238-S244, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37579203
5.
National trends in retreatment of HCV due to reinfection or treatment failure in Australia.
J Hepatol
; 78(2): 260-270, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152766
6.
Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection.
J Viral Hepat
; 30(1): 64-72, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36302162
7.
Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study.
Clin Infect Dis
; 75(10): 1809-1819, 2022 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35362522
8.
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.
Clin Infect Dis
; 75(1): 3-10, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34699587
9.
Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study.
J Viral Hepat
; 29(4): 271-279, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35175671
10.
Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort.
J Viral Hepat
; 2022 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35583922
11.
Australian consensus recommendations for the management of hepatitis B.
Med J Aust
; 216(9): 478-486, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35249220
12.
Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults.
Dig Dis Sci
; 67(6): 2600-2607, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33945063
13.
Concomitant Marked Decline in Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses Among Symptomatic Patients Following Public Health Interventions in Australia: Data from St Vincent's Hospital and Associated Screening Clinics, Sydney, NSW.
Clin Infect Dis
; 72(10): e649-e651, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32841316
14.
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study.
Clin Infect Dis
; 73(11): 2037-2044, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34107022
15.
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs.
Clin Infect Dis
; 72(8): 1392-1400, 2021 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32166305
16.
Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial.
Clin Infect Dis
; 73(7): e2164-e2172, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33010149
17.
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
PLoS Med
; 18(7): e1003656, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34228725
18.
High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia.
J Hepatol
; 74(2): 293-302, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32931879
19.
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection.
J Hepatol
; 75(4): 829-839, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023350
20.
Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection.
Hepatology
; 72(1): 7-18, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31652357